Real-time enrollment status for this blood cancer clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 8:00 PM UTC
| NCT Number | NCT07155226 |
| Recruiting Status | Recruiting |
| Condition | Blood Cancer |
| Phase | PHASE1 |
| Target Enrollment | 84 participants |
| Active Locations | 6 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | July 20, 2026 (Jul 20, 2026) |
As of August 29, 2026: Clinical trial NCT07155226 is currently recruiting participants. This phase1 study for blood cancer is actively seeking new participants at 6 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07155226 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07155226 was last updated Jul 20, 2026 (July 20, 2026). HelloStudys verifies this status automatically.